Krystal Biotech (NASDAQ:KRYS) director Dino Rossi sells $8.2m shares
Krystal Biotech director Dino A. Rossi sold about 25,000 shares for roughly $8.23m on Aug. 14, 2026, per an SEC Form 4, at weighted average prices of $325.60 to $333.23. He also gifted 3,691 shares to a donor-advised fund. Krystal Biotech reported Q2 diluted EPS of $1.79 (vs $1.70 est.) and revenue of $119.2m (vs $122.3m est.).
How this was made
The 30-second read
Why it matters
Insider selling can be a sentiment headwind, but without new guidance, financing, or regulatory/clinical catalysts, the trading signal is likely secondary to the company’s operating updates.
Market read
A director’s multi-million-dollar share sale is newly disclosed, but the article does not add a new fundamental catalyst beyond referencing recent earnings.
What to watch
The article also mentions a quarterly EPS beat but revenue miss; traders may weigh that more than the insider sale when forming near-term views.
Background
The piece centers on an SEC Form 4 by Krystal Biotech director Dino Rossi, alongside a brief recap of the company’s recent Q2 results.
Ticker impact
Krystal Biotech director Dino Rossi sold about $8.23m of KRYS shares on Aug. 14, per an SEC Form 4, with sale prices $325.60 to $333.23.
Near-term sentiment could soften, but magnitude is likely limited without accompanying guidance, financing, or operational news.
The article’s primary new fact is the director’s sale and a small charitable gift; it does not introduce new company fundamentals beyond referencing already-reported quarterly results.
Market effects
No clear sector read-through beyond routine insider activity in biotech.
None indicated.
None indicated.
Counterpoint
Director selling can be planned diversification or tax-related, so it may not signal deteriorating fundamentals.
Key entities
- companyKrystal Biotech, Inc.
NASDAQ-listed biotech whose director filed an SEC Form 4 reporting share sales and a charitable gift on Aug. 14, 2026.
- insiderDino A. Rossi
Director at Krystal Biotech who sold about 25,000 shares and made a charitable gift of 3,691 shares on Aug. 14, 2026.
